The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Open accessAbstract
Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In families affected with multiple cases of schizophrenia, the deficit in P50 gating segregates as an autosomal dominant and is linked to the CHRNA7 gene complex, which forms the α7-nicotinic acetylcholine receptor (26).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [26]
Citations
Cites
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citationStrategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
- L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
- W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
- L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
- L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
- M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
- L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
- 10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI
Cited by
Sorted by citations
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745
Rare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Intermediate phenotypes and genetic mechanisms of psychiatric disorders
Meyer-Lindenberg, A., & Weinberger, D. R. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1993 · Cited by 1,216
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., Williams, N. M., Schwab, S. G., Pulver, A. E., Faraone, S. V., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376549 · Cited by 1,134
Self-citationNeuronal nicotinic receptors in the human brain
Paterson, D., & Nordberg, A. K. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00045-3 · Cited by 792
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 751
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Self-citationMcCarley, R. W., Wible, C. G., Frumin, M., Hirayasu, Y., Levitt, J. J., Fischer, I. A., & Shenton, M. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00018-9 · Cited by 723
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 743
Schizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Self-citationTo Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
Lipska, B. K. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00137-8 · Cited by 663
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Meta-analysis of the P300 and P50 waveforms in schizophrenia
BRAMON, E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.004 · Cited by 569
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., D, A. O. M., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 575
Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia
D, A. O. M., Harris, J. G., Johnson, L. L., Pender, V., Kongs, S., Allensworth, D., Ellis, J., Zerbe, G. O., Leonard, S. S., Stevens, K. E., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.630 · Cited by 531
Self-citationSchizophrenia susceptibility loci on chromosomes 13q32 and 8p21
Blouin, J., Dombroski, B. A., Nath, S. K., Lasseter, V. K., Wolyniec, P. S., Nestadt, G., Thornquist, M. H., Ullrich, G., McGrath, J. A., Kasch, L. M., et al. (1998) · Nature Genetics · doi:10.1038/1734 · Cited by 531
Realistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
The Pathophysiology of Schizophrenia Disorders: Perspectives From the Spectrum
Siever, L. J., & Davis, K. L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.398 · Cited by 510
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador‐Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 501
Prefrontal cortex regulates inhibition and excitation in distributed neural networks
Knight, R. T., Richard Staines, W., Swick, D., & Chao, L. L. (1999) · Acta Psychologica · doi:10.1016/s0001-6918(99)00004-9 · Cited by 498
Orr‐Urtreger, A., Göldner, F. M., Saeki, M., Lorenzo, I., Goldberg, L. B., Biasi, M. D., Dani, J. A., Patrick, J. W., & Beaudet, A. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09165.1997 · Cited by 494
Self-citationThe endophenotype concept in psychiatric genetics
FLINT, J., & MUNAFÒ, M. R. (2007) · Psychological Medicine · doi:10.1017/s0033291706008750 · Cited by 477
Nicotine use in schizophrenia: The self medication hypotheses
Kumari, V., & Postma, P. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.02.006 · Cited by 470
BRAFF, D. L., Freedman, R., Schork, N. J., & Gottesman, I. I. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl049 · Cited by 454
Self-citationNicotinic ACh receptors as therapeutic targets in CNS disorders
Dineley, K. T., Pandya, A. A., & Yakel, J. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.12.002 · Cited by 460
Hurst, R. S., Hajós, M., Raggenbass, M., Wall, T. M., Higdon, N. R., Lawson, J. A., Rutherford-Root, K. L., Berkenpas, M. B., Hoffmann, W. E., Piotrowski, D. W., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5269-04.2005 · Cited by 447
Nicotinic acetylcholine receptors in health and disease
Lindstrom, J. (1997) · Molecular Neurobiology · doi:10.1007/bf02740634 · Cited by 443
Leonard, S. S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C. J., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 443
Self-citationCallicott, J. H., Egan, M. F., Mattay, V. S., Bertolino, A., Bone, A. D., Verchinksi, B., & Weinberger, D. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.709 · Cited by 440
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
Self-citationHuman neuronal nicotinic receptors
Gotti, C., Fornasari, D., & Clementi, F. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00034-8 · Cited by 417
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 430
Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
Javitt, D. C., & Freedman, R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121691 · Cited by 403
Self-citationEffects of nicotinic stimulation on cognitive performance
NEWHOUSE, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 411
The Consortium on the Genetics of Schizophrenia: Neurocognitive Endophenotypes
Gur, R. C., Calkins, M. E., Gur, R. C., Horan, W. P., Nuechterlein, K. H., Seidman, L. J., & Stone, W. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl055 · Cited by 393
Initial Heritability Analyses of Endophenotypic Measures for Schizophrenia
Greenwood, T. A., BRAFF, D. L., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. E., Gur, R. C., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1242 · Cited by 382
Self-citationThe Inheritance of Neuropsychological Dysfunction in Twins Discordant for Schizophrenia
Cannon, T. D., HUTTUNEN, M. O., Lönnqvist, J. K., Tuulio‐Henriksson, A., Pirkola, T., Glahn, D. C., Finkelstein, J. R. J., Hietanen, M., Kaprio, J. A., & Koskenvuo, M. J. (2000) · The American Journal of Human Genetics · doi:10.1086/303006 · Cited by 369
Addressing tobacco among individuals with a mental illness or an addiction
Williams, J. M., & Ziedonis, D. M. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.03.009 · Cited by 356
Genes and the parsing of cognitive processes
Goldberg, T. E., & Weinberger, D. R. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.05.011 · Cited by 356
Nicotinic receptors in the brain. Links between molecular biology and behavior
Picciotto, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00146-3 · Cited by 354
Cadenhead, K. S., Swerdlow, N. R., Shafer, K. M., Díaz, M. M., & BRAFF, D. L. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1660 · Cited by 354
P50 sensory gating ratios in schizophrenics and controls: A review and data analysis
Patterson, J. V., Hetrick, W. P., Boutros, N. N., Jin, Y., Sandman, C. A., Stern, H. S., Potkin, S. G., & Bunney, W. E. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.02.009 · Cited by 352
Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia
Breese, C. R. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00121-4 · Cited by 343
Self-citationAlpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 341
Self-citationNeurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K., Thaker, G. K., Winterer, G., & Hajós, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 340
Alkondon, M., Pereira, E. F. R., Eisenberg, H. M., & Albuquerque, E. X. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02693.1999 · Cited by 332
Effects of Cigarette Smoking on Spatial Working Memory and Attentional Deficits in Schizophrenia
Sacco, K. A., Termine, A., Seyal, A. A., Dudas, M. M., Vessicchio, J. C., Krishnan‐Sarin, S., Jatlow, P. I., Wexler, B. E., & George, T. P. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.649 · Cited by 331
Evaluating historical candidate genes for schizophrenia
Farrell, M. S., Werge, T., Sklar, P., Owen, M. J., Ophoff, R. A., O'Donovan, M. C., Corvin, A., Cichon, S., & Sullivan, P. F. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.16 · Cited by 315
Mount, D. B., Mercado, A., Song, L., Xu, J. Z., George, A. L., Delpire, E. J., & Gamba, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16355 · Cited by 313
Genes, environment and schizophrenia
Tsuang, M. T., Stone, W. S., & Faraone, S. V. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.40.s18 · Cited by 313
Assessing the heritability of attentional networks
Fan, J., Wu, Y., Fossella, J., & Posner, M. I. (2001) · BMC Neuroscience · doi:10.1186/1471-2202-2-14 · Cited by 324
Maelicke, A., Samochocki, M., Jostock, R., Fehrenbacher, A., Ludwig, J., Albuquerque, E. X., & Zerlin, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01109-4 · Cited by 303
Structure and gating mechanism of the α7 nicotinic acetylcholine receptor
Noviello, C., Gharpure, A., Mukhtasimova, N., Cabuco, R., Baxter, L., Borek, D., Sine, S. M., & Hibbs, R. E. (2021) · Cell · doi:10.1016/j.cell.2021.02.049 · Cited by 313
Paylor, R., Nguyen, M., Crawley, J. N., Patrick, J., Beaudet, A., & Orr-Urtreger, A. (1998) · Learning & Memory · doi:10.1101/lm.5.4.302 · Cited by 298
Self-citationLeonard, S. S., Adler, L. E., Benhammou, K., Berger, R., Breese, C. R., Drebing, C. J., Gault, J., Lee, M. J., Logel, J., D, A. O. M., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00677-3 · Cited by 298
Self-citationKoenig, J. I., Elmer, G. I., Shepard, P. D., Lee, P. R., Mayo, C. L., Joy, B., Hercher, E., & Brady, D. L. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.05.030 · Cited by 297
Incidence of Cancer Among Persons With Schizophrenia and Their Relatives
Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., & Lönnqvist, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.573 · Cited by 292
Mouse genetic models for prepulse inhibition: an early review
Geyer, M. A., McIlwain, K. L., & Paylor, R. E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001159 · Cited by 289
Impact of prepulse characteristics on the detection of sensorimotor gating deficits in schizophrenia
BRAFF, D. L., Geyer, M. A., Light, G. A., Sprock, J., Perry, W., Cadenhead, K. S., & Swerdlow, N. R. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00139-0 · Cited by 288
Howard, H. C., Mount, D. B., Rochefort, D. L., Byun, N. E., Dupré, N., Lü, J., Fan, X., Song, L., Rivière, J., Prévost, C., et al. (2002) · Nature Genetics · doi:10.1038/ng1002 · Cited by 283
Relative risk for cognitive impairments in siblings of patients with schizophrenia
Egan, M. F., Goldberg, T. E., Gscheidle, T., Weirich, M. L., Rawlings, R. R., Hyde, T. M., Bigelow, L. B., & Weinberger, D. R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01133-7 · Cited by 282
Schizophrenia: from phenomenology to neurobiology
Wong, A. H. C., & Tol, H. H. M. V. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00035-6 · Cited by 292
Straub, R. E., Lipska, B. K., Egan, M. F., Goldberg, T. E., Callicott, J. H., Mayhew, M. B., Vakkalanka, R., Kolachana, B. S., Kleinman, J. E., & Weinberger, D. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001988 · Cited by 275
Poor P50 Suppression Among Schizophrenia Patients and Their First-Degree Biological Relatives
Clementz, B. A., Geyer, M. A., & BRAFF, D. L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1691 · Cited by 275
Hong, L. E., Summerfelt, A., Buchanan, R. W., O'Donnell, P., Thaker, G. K., Weiler, M. A., & Lahti, A. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.168 · Cited by 274
Are schizophrenic and bipolar disorders related? A review of family and molecular studies
Berrettini, W. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00883-0 · Cited by 272
Liu, J., Pearlson, G. D., Windemuth, A., Ruaño, G., Perrone‐Bizzozero, N. I., & Calhoun, V. D. (2007) · Human Brain Mapping · doi:10.1002/hbm.20508 · Cited by 271
Implications of CYP2A6 Genetic Variation for Smoking Behaviors and Nicotine Dependence*
Malaiyandi, V., Sellers, E. M., & Tyndale, R. F. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.011 · Cited by 269
Electroencephalography (EEG) and Event‐Related Potentials (ERPs) with Human Participants
Light, G. A., Williams, L. E., Minow, F., Sprock, J., Rissling, A. J., Sharp, R. F., Swerdlow, N. R., & BRAFF, D. L. (2010) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0625s52 · Cited by 266
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264
Glahn, D. C., Bearden, C. E., Niendam, T. A., & Escamilla, M. A. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00113.x · Cited by 259
Review of Clinical Correlates of P50 Sensory Gating Abnormalities in Patients with Schizophrenia
Potter, D., Summerfelt, A. T., Gold, J. M., & Buchanan, R. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj050 · Cited by 258
Greenwood, T. A., Lazzeroni, L. C., Murray, S. S., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Green, M. F., Gur, R. E., Gur, R. C., Hardiman, G., et al. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10050723 · Cited by 257
Self-citationNeuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia
COURT, J. A., Spurden, D., Lloyd, S. R., McKeith, I. G., Ballard, C. G., Cairns, N. J., Kerwin, R. W., Perry, R., & Perry, E. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731590.x · Cited by 252
Alkondon, M., Pereira, E. F. R., Eisenberg, H. M., & Albuquerque, E. X. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00066.2000 · Cited by 248
Smith, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00324-x · Cited by 249
Gault, J., Robinson, M., Berger, R., Drebing, C. J., Logel, J., Hopkins, J., Moore, T., Jacobs, S., Meriwether, J., Choi, M. J., et al. (1998) · Genomics · doi:10.1006/geno.1998.5363 · Cited by 245
Self-citationBarr, R. S., Maravić, M. C., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., Deckersbach, T., Kelly, J. F., Freudenreich, O., GOFF, D. C., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301423 · Cited by 242
Why do patients with schizophrenia smoke?
Winterer, G. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283366643 · Cited by 238
Effects of Nicotine on Cognitive Deficits in Schizophrenia
Harris, J. G., Kongs, S., Allensworth, D., Martín, L., Tregellas, J. R., Sullivan, B. F., Zerbe, G. O., & Freedman, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300450 · Cited by 235
Self-citationGene Expression Profile for Schizophrenia
Hemby, S. E., Ginsberg, S. D., Brunk, B. P., Arnold, S. E., Trojanowski, J. Q., & Eberwine, J. H. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.631 · Cited by 234
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233
Williams, J. T., Eerdewegh, P. V., Almasy, L. A., & Blangero, J. (1999) · The American Journal of Human Genetics · doi:10.1086/302570 · Cited by 234
Nicotine effects on brain function and functional connectivity in schizophrenia
Jacobsen, L. K., D’Souza, D. C., Mencl, W. E., Pugh, K. R., Skudlarski, P., & Krystal, J. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.023 · Cited by 236
Nicotinic Receptor-Induced Apoptotic Cell Death of Hippocampal Progenitor Cells
Berger, F. R., Gage, F. H., & Vijayaraghavan, S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-17-06871.1998 · Cited by 234
Levine, E. M., Passini, M. A., Hitchcock, P. F., Glasgow, E. F., & Schechter, N. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971027)387:3 · Cited by 53
Self-citationJones, C. K., Byun, N. E., & Bubser, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.199 · Cited by 241
Hajós, M., Hurst, R. S., Hoffmann, W. E., Krause, M., Wall, T. M., Higdon, N. R., & Groppi, V. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076968 · Cited by 225
Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
Wallace, T. L., & Porter, R. H. P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.034 · Cited by 229
Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia
Gray, J. A., & Roth, B. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm074 · Cited by 227
Maelicke, A., & Albuquerque, E. X. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00093-5 · Cited by 224
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Young, J. W., Finlayson, K., Spratt, C., Marston, H. M., Crawford, N., Kelly, J. S., & Sharkey, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300393 · Cited by 219
Splitting Schizophrenia: Periodic Catatonia–Susceptibility Locus on Chromosome 15q15
Stöber, G., Saar, K., Rüschendorf, F., Meyer, J., Nürnberg, G., Jatzke, S., Franzek, E., Reis, A., Lesch, K., Wienker, T. F., et al. (2000) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)62950-4 · Cited by 219
Timmermann, D. B., Grønlien, J. H., Kohlhaas, K. L., Nielsen, E. Ø., Dam, E., Dyhring, T., Ahring, P. K., Peters, D., Holst, D., Chrsitensen, J. K., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120436 · Cited by 217
Metadata
- Authors
- Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
- Affiliations
- Baylor College of Medicine (US)
- Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19557
- OpenAlex
- W2144671685
- Cited by
- 1,141
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
- National Institute on Aging (T32AG000029)
- National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
- National Institute on Drug Abuse (R01DA009457)
- National Center for Research Resources (P41RR003655, M01RR000064)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
- MeSH terms
- Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
